↓ Skip to main content

Sorafenib for Advanced and Refractory Desmoid Tumors

Overview of attention for article published in New England Journal of Medicine, December 2018
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (99th percentile)
  • Good Attention Score compared to outputs of the same age and source (75th percentile)

Readers on

mendeley
279 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.

Login to access the Attention Digest and the Sentiment Analysis related to this output.

Timeline Attention over time Attention Score history
Login to access the full charts related to this output.
Activity
Login to access the full charts related to this output.
X Demographics

X Demographics

The data shown below were collected from the profiles of 112 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley demographics

Mendeley demographics

The data shown below were compiled from readership statistics for 279 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Login to view Mendeley reader trends over time.

Geographical breakdown

Geographical breakdown
Country Count As %
Unknown 279 100%

Demographic breakdown

Readers by professional status
Readers by professional status Count As %
Other 29 10%
Researcher 24 9%
Student > Postgraduate 22 8%
Student > Ph. D. Student 21 8%
Student > Master 21 8%
Other 50 18%
Unknown 112 40%
Readers by discipline
Readers by discipline Count As %
Medicine and Dentistry 102 37%
Nursing and Health Professions 15 5%
Biochemistry, Genetics and Molecular Biology 14 5%
Pharmacology, Toxicology and Pharmaceutical Science 7 3%
Agricultural and Biological Sciences 5 2%
Other 17 6%
Unknown 119 43%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 204. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 04 May 2026.
All research outputs
#242,912
of 34,492,055 outputs
Outputs from New England Journal of Medicine
#4,513
of 38,491 outputs
Outputs of similar age
#4,069
of 487,930 outputs
Outputs of similar age from New England Journal of Medicine
#64
of 258 outputs
Altmetric has tracked 34,492,055 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 38,491 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 120.2. This one has done well, scoring higher than 88% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 487,930 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 258 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 75% of its contemporaries.